Application Information

This drug has been submitted to the FDA under the reference 203414/001.

Names and composition

"KAZANO" is the commercial name of a drug composed of ALOGLIPTIN BENZOATE and METFORMIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
203414/001 KAZANO ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET/ORAL EQ 12.5MG BASE and 500MG
203414/002 KAZANO ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET/ORAL EQ 12.5MG BASE and 1GM

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
203414/001 KAZANO ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET/ORAL EQ 12.5MG BASE and 500MG
203414/002 KAZANO ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET/ORAL EQ 12.5MG BASE and 1GM

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved